"Every person’s experience of cancer is different, which is why clinically led, personalised support is so important."
- Nikki Cannon - Reframe Cancer
Reframe Cancer has announced the appointment of Emma Thomson as head of commercial partnerships and the promotion of Nikki Cannon to director of clinical affairs.
The cancer screening and navigation business says the appointments reflect its focus on expanding access to specialist cancer navigation services and combining commercial partnerships with clinical expertise.
Having previously worked with Reframe Cancer as a consultant, Emma Thomson will focus on developing strategic partnerships with insurers, employers and distributors, helping extend access to Reframe Cancer’s CQC-regulated screening, early detection, and cancer navigation services.
Nikki Cannon has a nursing background and over 30 years’ experience in cancer care. She will lead Reframe's clinical engagement with charities, professional bodies, and healthcare networks.
READ MORE: Uinsure appoints new chief trading officer
"Having worked with Reframe Cancer as a consultant for nearly two years, I have seen first-hand the value its services provide to individuals, families, employers and insurers," Emma Thomson said.
"I am delighted to be joining the team permanently and look forward to building partnerships that enable more people affected by cancer to access expert, personalised support when they need it."
Nikki Cannon, Reframe Cancer, added: "Every person’s experience of cancer is different, which is why clinically led, personalised support is so important. I am delighted to take on this new role and strengthen our work with the charities, clinicians, and health systems we work alongside.
"My focus will be on ensuring everything we do is shaped by clinical evidence, helping more people access the right support at the right time, from understanding their cancer risk through to treatment and beyond."
